Medtech: Employment Up, Industry “Picking Up Steam”
Medtech employment remained steady in last year with most medical device makers experiencing an increase in their workforce, according to a new jobs report published by EP Vantage.
Medtech employment remained steady in last year with most medical device makers experiencing an increase in their workforce, according to a new jobs report published by EP Vantage.
Of the top 15 device makers, only three experienced a reduction in headcount and two of those were due to companies spinning off their respective pharmaceutical operations, the report shows. Otherwise the top 15 largest medtech firms managed to grow their workforces by an average of 6 percent.
Companies including Baxter International and Stryker grew through multibillion-dollar acquisitions of other medtech companies. Baxter was the fastest growing among the top 15 companies in 2013 thanks in part to its acquisition of Gambro, which added 10,000 employees for a growth rate of 20 percent.
“[With] several megamergers underway, we can expect to see much more drastic changes in device makers’ headcounts in the coming years,”commented Elizabeth Cairns, the report’s author.
However, acquisitions did not play a role for the number two-ranked hirer, Intuitive Surgical. Despite a tumultuous year, the firm brought on 28 new salespeople in 2013, an increase of 30 percent.
For more on the report report, visit www.evaluategroup.com/MedtechJobNumbers
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Pfizer, GSK Gain ACIP Recommendations for RSV and Meningococcal Vaccines
April 18th 2025The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to Pfizer’s respiratory syncytial virus vaccine Abrysvo for high-risk adults in their 50s and voted in favor of GSK’s meningococcal vaccine, Penmenvy, for streamlined adolescent protection.
